Otsuka Holdings
4578.T
#747
Rank
S$40.41 B
Marketcap
S$76.52
Share price
0.21%
Change (1 day)
-0.90%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: S$1.36 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are S$14.47 Billion. In 2023 the company made an earning of S$1.36 Billion a decrease over its 2022 earnings that were of S$1.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023S$1.36 B-20.93%
2022S$1.72 B-12.7%
2021S$1.97 B-19.92%
2020S$2.46 B13.9%
2019S$2.16 B52.07%
2018S$1.42 B11.22%
2017S$1.28 B-36.03%
2016S$2.00 B31.15%
2015S$1.52 B
2013S$3.16 B33.52%
2012S$2.37 B-4.65%
2011S$2.48 B45.53%
2010S$1.70 B